Mutations in the gene encoding for the gap junction protein Cx47 (GJC2) have been described as causal variants in primary lymphedema (60, 61); however, the expression of GJC2 mRNA was not significantly changed in cultured hLECs upon treatment with CGRP for 8 hours (Figure 4A). The gene discussed is GJC2; the disease is primary lymphedema.